ES8106408A1 - Procedimiento para preparar una composicion de ubidecarenona - Google Patents

Procedimiento para preparar una composicion de ubidecarenona

Info

Publication number
ES8106408A1
ES8106408A1 ES493679A ES493679A ES8106408A1 ES 8106408 A1 ES8106408 A1 ES 8106408A1 ES 493679 A ES493679 A ES 493679A ES 493679 A ES493679 A ES 493679A ES 8106408 A1 ES8106408 A1 ES 8106408A1
Authority
ES
Spain
Prior art keywords
absorption
ubidecarenone
composition enhancing
ubidecarenone composition
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493679A
Other languages
English (en)
Spanish (es)
Other versions
ES493679A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES493679A0 publication Critical patent/ES493679A0/es
Publication of ES8106408A1 publication Critical patent/ES8106408A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES493679A 1979-07-25 1980-07-24 Procedimiento para preparar una composicion de ubidecarenona Expired ES8106408A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9363679A JPS5618914A (en) 1979-07-25 1979-07-25 Ubidecarenone composition having good absorbability

Publications (2)

Publication Number Publication Date
ES493679A0 ES493679A0 (es) 1981-07-01
ES8106408A1 true ES8106408A1 (es) 1981-07-01

Family

ID=14087821

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493679A Expired ES8106408A1 (es) 1979-07-25 1980-07-24 Procedimiento para preparar una composicion de ubidecarenona

Country Status (7)

Country Link
US (1) US4325942A (enExample)
EP (1) EP0023349B1 (enExample)
JP (1) JPS5618914A (enExample)
CA (1) CA1159767A (enExample)
DE (1) DE3070508D1 (enExample)
ES (1) ES8106408A1 (enExample)
PH (1) PH16762A (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
EP0104043A3 (en) * 1982-09-20 1984-06-06 Ajinomoto Co., Inc. Foodstuffs and pharmaceuticals
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4824669A (en) * 1985-04-11 1989-04-25 Board Of Regents, The University Of Texas System Formulations of coenzyme Q10 for intravenous use
JPH0629180B2 (ja) * 1986-06-16 1994-04-20 エーザイ株式会社 吸収性の改良されたメナテトレノン含有組成物
EP0287646B1 (en) * 1986-10-23 1992-05-20 Arval S.P.A. Cosmetic preparations containing ubidecarenones
JPS63188623A (ja) * 1987-01-31 1988-08-04 Taisho Pharmaceut Co Ltd 吸収改善ユビデカレノン製剤
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US5189066A (en) * 1989-11-22 1993-02-23 The Procter & Gamble Company Pharmaceutical compositions of tebufelone
EP0448091B1 (en) * 1990-03-23 1998-08-05 The Green Cross Corporation Pharmaceutical composition containing slightly water-soluble drug
US5571517A (en) * 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5891466A (en) * 1990-08-13 1999-04-06 Yesair; David W. Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories
WO1992003121A1 (en) * 1990-08-13 1992-03-05 Yesair David W Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
JP3106820B2 (ja) * 1993-12-08 2000-11-06 アールティーエー・アソシエーツ有限会社 畜肉、魚肉およびこれらの加工品の鮮度保持剤並びに生産性改善剤
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
BR9810866B1 (pt) * 1997-07-29 2010-07-13 composição farmacêutica em uma forma de formulação auto-emulsificante para compostos lipofìlicos.
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
DE10133305B4 (de) * 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat
JP2003055204A (ja) * 2001-08-21 2003-02-26 Sansho Iyaku Kk ユビデカレノン組成物及び同組成物を内容物とするカプセル
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
CA2513276C (en) * 2003-01-17 2012-09-04 Taiyo Kagaku Co., Ltd. Compositions containing coenzyme q10
JP4567945B2 (ja) * 2003-01-17 2010-10-27 太陽化学株式会社 ユビデカレノン製剤
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
JP5258144B2 (ja) * 2004-12-21 2013-08-07 株式会社分子生理化学研究所 吸収性の改善された固形状のコエンザイムｑ１０経口製剤の製造方法
US8491888B2 (en) * 2006-05-05 2013-07-23 Softgel Formulators, Inc. Highly absorbable coenzyme Q10 composition and method of producing same
JP5181497B2 (ja) * 2007-03-05 2013-04-10 大正製薬株式会社 ユビデカレノン含有固形製剤用組成物
EP3366280A1 (en) 2010-03-12 2018-08-29 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426125A (en) * 1965-04-07 1969-02-04 Yukio Shigeta Method of treating diabetes mellitus
US3317381A (en) * 1965-10-04 1967-05-02 Takeda Chemical Industries Ltd Method for treating peptic ulcer
US3534137A (en) * 1965-09-30 1970-10-13 Takeda Chemical Industries Ltd Method of systemic therapy for severe early destructive periodontal disease
US3452144A (en) * 1966-03-26 1969-06-24 Takeda Chemical Industries Ltd Method for treatment of congestive heart failure with coenzyme qn
US3808330A (en) * 1972-07-13 1974-04-30 Eisai Co Ltd Method for treatment of hypertensive disease
DE2631282A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
DE2700371A1 (de) * 1977-01-07 1978-07-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung fester und fluessiger loesungen von arzneistoffen zur oralen applikation
DE2700433A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Arzneimittelzubereitungen mit verbesserten resorptionseigenschaften
DE2700501A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung fester und fluessiger loesungen von arzneistoffen zur oralen applikation

Also Published As

Publication number Publication date
CA1159767A (en) 1984-01-03
EP0023349A3 (en) 1982-03-10
JPS6410494B2 (enExample) 1989-02-22
PH16762A (en) 1984-02-15
US4325942A (en) 1982-04-20
ES493679A0 (es) 1981-07-01
EP0023349A2 (en) 1981-02-04
DE3070508D1 (en) 1985-05-23
EP0023349B1 (en) 1985-04-17
JPS5618914A (en) 1981-02-23

Similar Documents

Publication Publication Date Title
ES8106408A1 (es) Procedimiento para preparar una composicion de ubidecarenona
EP0031353A4 (fr) Utilisation de carbone perfluore pour le traitement des brulures.
GB2047563B (en) Emulsifier composition
ZA806626B (en) Absorbent products,processes and compositions
PT68003A (en) Compounds and compositions.
IL50011A (en) N-substituted3-trifuloromethyl-phenyl-n-benzoyl ureas,their preparation and insecticidal compositions containing the
JPS53130488A (en) Glycerol-oxydase, its preparation, and determination of glycerol using glycerol-oxydase
GB2027717B (en) Enzymatic diagnostic composition
KE3232A (en) 2-formylquinoxaline-1,4-dioxide cyanoacetylhydrazones,processes for the preparation thereof and compositions containing same
DE2960538D1 (en) Halogenated phenolic esters, germ-killing compositions containing them, and their use
JPS57115416A (en) Storage-stable composition
JPS55141194A (en) Standard enzyme composition
PH14944A (en) Sh-indeno 2,1-b thiophen-2-oxaminic acids,esters thereof and compositions containing the same
DE3060590D1 (en) Tert. butoxybutanales and butanoles and bis-tert. butoxy-pentanales and pentanoles, their production and their use as perfumes
IL60604A (en) 4-fluoro-3-bromo-benzoyl-fluoride,its preparation and its use for the preparation of the alpha-cyano-4-fluoro-3-phenoxybenzyl ester of permethric acid
JPS51119498A (en) Radial ray sheltering cover sheet
PH17545A (en) Absorbent products,processes and compositions
AR223981A1 (es) Procedimiento para la fabricacion del compuesto m.139.603,mezcla y extracto de fermentacion y composicion
IL54598A0 (en) Novel benzylpyrimidines, their manufacture and pharmaceutiical compositions containing them
JPS5350397A (en) Preparation of 4-hydroxycyclopent-2-ene-1-one
JPS53141241A (en) N-p-aminobenzyl-n'-p-aminophenylurea and process for its preparation
JPS5218834A (en) Long-acting perfumery composition
JPS53111050A (en) 4-exo-acyloxy-4-homotwistane, and perfume and flavor composition containing the same
JPS5428892A (en) 16m-macrolide-3-hydrolase, its preparation, and its use
JPS5576815A (en) Methyldopa composition

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603